1. Volume 2(Supplement 1):4-7
Building a sickle cell disease screening program in the Republic of Uganda: the Uganda Sickle Surveillance Study (US3) with 3 years of follow-up screening results
by Charles Kiyaga, Arielle G. Hernandez, Isaac Ssewanyana, Kathryn E. McElhinney, Grace Ndeezi, Thad A. Howard, Christopher M. Ndugwa, Russell E. Ware, and Jane R. Aceng
BloodAdv
Volume 2(Supplement 1):4-7
November 30, 2018
© 2018 by The American Society of Hematology

2. Charles Kiyaga et al. Blood Adv 2018;2:4-7
© 2018 by The American Society of Hematology

3. Charles Kiyaga et al. Blood Adv 2018;2:4-7
© 2018 by The American Society of Hematology

4. Charles Kiyaga et al. Blood Adv 2018;2:4-7
© 2018 by The American Society of Hematology

5. Charles Kiyaga et al. Blood Adv 2018;2:4-7
© 2018 by The American Society of Hematology

6. Prevalence of sickle cell trait in 112 districts in Uganda.
Prevalence of sickle cell trait in 112 districts in Uganda. Reproduced from Ndeezi G et al, Lancet Glob Health. 2016;4(3):e195-e200, with permission.
Charles Kiyaga et al. Blood Adv 2018;2:4-7
© 2018 by The American Society of Hematology

7. Charles Kiyaga et al. Blood Adv 2018;2:4-7
© 2018 by The American Society of Hematology